AREX Capital Management LP Has $19.45 Million Holdings in Enhabit, Inc. (NYSE:EHAB)

AREX Capital Management LP lifted its holdings in Enhabit, Inc. (NYSE:EHAB - Free Report) by 2.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,490,795 shares of the company's stock after purchasing an additional 48,874 shares during the period. Enhabit comprises 27.7% of AREX Capital Management LP's holdings, making the stock its biggest holding. AREX Capital Management LP owned about 4.95% of Enhabit worth $19,453,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. boosted its position in shares of Enhabit by 37.8% in the third quarter. JPMorgan Chase & Co. now owns 305,245 shares of the company's stock worth $2,411,000 after buying an additional 83,707 shares during the period. Paradice Investment Management LLC grew its stake in Enhabit by 12.8% during the 4th quarter. Paradice Investment Management LLC now owns 1,780,113 shares of the company's stock valued at $13,903,000 after acquiring an additional 201,997 shares in the last quarter. Corient Private Wealth LLC acquired a new position in shares of Enhabit in the 4th quarter valued at about $79,000. Rhumbline Advisers lifted its position in shares of Enhabit by 2.8% in the fourth quarter. Rhumbline Advisers now owns 80,760 shares of the company's stock worth $631,000 after purchasing an additional 2,211 shares in the last quarter. Finally, Empowered Funds LLC grew its position in Enhabit by 5.0% during the fourth quarter. Empowered Funds LLC now owns 175,824 shares of the company's stock valued at $1,373,000 after purchasing an additional 8,448 shares in the last quarter.

Enhabit Price Performance

Shares of EHAB traded up $1.24 during trading hours on Thursday, hitting $9.44. The stock had a trading volume of 342,881 shares, compared to its average volume of 481,129. The stock has a market capitalization of $478.01 million, a price-to-earnings ratio of -4.07 and a beta of 1.61. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.46 and a quick ratio of 1.46. The company's fifty day moving average is $8.26 and its two-hundred day moving average is $8.04. Enhabit, Inc. has a 52 week low of $6.85 and a 52 week high of $10.70.

Enhabit (NYSE:EHAB - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.10 EPS for the quarter, beating analysts' consensus estimates of $0.07 by $0.03. Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. The firm had revenue of $259.90 million for the quarter, compared to analyst estimates of $266.11 million. On average, analysts anticipate that Enhabit, Inc. will post 0.22 EPS for the current year.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group reiterated a "buy" rating on shares of Enhabit in a report on Thursday, March 6th.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.